What is a bivalent HPV vaccine?

Cervical cancer is caused by HPV infection. It is caused by HPV infection. After the cause is clear, primary prevention can be carried out. Vaccination can block most cervical cancer and block more than 90% of cervical cancer. The often said bivalent HPV vaccine is mainly for women aged 9-45, mainly for two viruses, namely high-risk viruses 16 and 18, because 16 and 18 are responsible for 70% of cervical cancer, so if intramuscular injection of these two types can effectively prevent cervical cancer. This bivalent vaccine is produced by GlaxoSmithKline and launched in 2007. It is produced in Belgium. Its vaccination time is 0,1 and 6. This vaccine is usually three doses.